Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: A case-control study

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 2, 2010, Pages 300-305

  Silverberg, Jonathan I ^a,b,c   Norowitz, Kevin B ^a   Kleiman, Edward ^a   Silverberg, Nanette B ^b   Durkin, Helen G ^a   Joks, Rauno ^a   Smith Norowitz, Tamar A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c SUNY Downstate Medical Center   (United States)

Author keywords

Allergic rhinitis; Asthma; Atopic dermatitis; Atopy; Chickenpox; Eczema; Food allergy; Rhinoconjunctivitis; Varicella vaccine; Varicella zoster virus; Varivax

Indexed keywords

EID: 77955926246     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.05.041     Document Type: Article

References (70)

1. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000;43:649-55.
2. Wuthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999;83:464-70.
3. Wuthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome: epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS. J Investig Allergol Clin Immunol 2003;13:1-5.
4. Taylor B, Wadsworth M, Wadsworth J, Peckham C. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984;324:1255-7.
5. Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006;118:209-13.
6. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008;121:947-54, e15.
7. Schultz Larsen F, Hanifin JM. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:7-12.
8. Schultz Larsen F. The epidemiology of atopic dermatitis. Monogr Allergy 1993;31:9-28.
9. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996;34:760-4.
10. O'Connell EJ. The burden of atopy and asthma in children. Allergy 2004; 59(suppl 78):7-11.
11. Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 2006;126:1200-2.
12. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
13. Sandilands A, Terron-Kwiatkowski A, Hull PR, O'Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007;39:650-4.
14. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006;118:214-9.
15. Sandilands A, O'Regan GM, Liao H, Zhao Y, Terron-Kwiatkowski A, Watson RM, et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 2006; 126:1770-5.
16. Rodriguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009;123:1361-70, e7.
17. Rodriguez S, Hall AJ, Granell R, McLean WH, Irvine AD, Palmer CN, et al. Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort. PLoS One 2009;4:e5784.
18. O'Regan GM, Irvine AD. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 2008;8:406-10.
19. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008;122:689-93.
20. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-60.
21. Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007;212:441-52.
22. von Mutius E. Allergies, infections and the hygiene hypothesis-the epidemiolog- ical evidence. Immunobiology 2007;212:433-9.
23. Wang DY. Risk factors of allergic rhinitis: genetic or environmental? Ther Clin Risk Manag 2005;1:115-23.
24. Calvani M, Alessandri C, Paolone G, Rosengard L, Di Caro A, De Franco D. Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease. Pediatr Allergy Immunol 1997;8:91-6.
25. Lev Tov H, Josekutty J, Kohlhoff S, Norowitz KB, Silverberg JI, Chice S, Nowa-kowski M, et al. IgE anti-varicella virus (VZV) and other immune responses before, during, and after shingles. J Allergy Clin Immunol 2008;121:S207.
26. Nilsson C, Linde A, Montgomery SM, Gustafsson L, Nasman P, Blomberg MT, et al. Does early EBV infection protect against IgE sensitization? J Allergy Clin Immunol 2005;116:438-44.
27. Illi S, von Mutius E, Lau S, Bergmann R, Niggemann B, Sommerfeld C, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001;322:390-5.
28. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the ''hygiene hypothesis'': too clean to be true? Br J Dermatol 2005;152:202-16.
29. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92:44-7.
30. Rothe M, Grant-Kels J. Diagnostic criteria for atopic dermatitis. Lancet 1996;348:769-70.
31. American Academy of PediatricsCommittee on Infectious Diseases. Varicella vaccine update. Pediatrics 2000;105:136-41.
32. Chow S-C, Shao J, Wang H. Sample size calculations in clinical research. New York: Marcel Dekker; 2003.
33. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008;122:e744-51.
34. Chakravarti IM, Laha RG, Roy J, editors. Handbook of methods of applied statistics. New York: Wiley; 1967.
35. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
36. Benjamini Y, Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289-300.
37. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001;29:1165-88.
38. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
39. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
40. Silverberg JI, Norowitz KB, Kleiman E, Durkin HG, Smith-Norowitz TA. Varicella zoster virus (wild-type) infection, but not varicella vaccine, in late childhood is associated with delayed asthma onset, milder symptoms, and decreased atopy. Pediatr Asthma Allergy Immunol 2009;22:15-20.
41. Gillet Y, Habermehl P, Thomas S, Eymin C, Fiquet A. Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial. BMC Med 2009;7:16.
42. Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, et al. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age. Vaccine 2009;27:2701-6.
43. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005;352:450-8.
44. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005;294:797-802.
45. Hanifin JM, Reed ML. A population-based survey of eczema prevalence in the United States. Dermatitis 2007;18:82-91.
46. Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF. An economic analysis of the universal varicella vaccination program in the United States. J Infect Dis 2008;197(suppl 2):S156-64.
47. Bonanni P, Boccalini S, Bechini A, Banz K. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden ofuncomplicated hospitalised cases. Vaccine 2008;26:5619-26.
48. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000;343:538-43.
49. Martinez FD. Maturation of immune responses at the beginning of asthma. J Allergy Clin Immunol 1999;103:355-61.
50. Hambleton S. Chickenpox. Curr Opin Infect Dis 2005;18:235-40.
51. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006;117:176-83.
52. Fujimura T, Yamanashi R, Masuzawa M, Fujita Y, Katsuoka K, Nishiyama S, et al. Conversion of the CD41 T cell profile from T(H2)-dominant type to T(H1)- dominant type after varicella-zoster virus infection in atopic dermatitis. J Allergy Clin Immunol 1997;100:274-82.
53. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 1998;178:940-8.
54. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981;305:841-6.
55. Bui RH, Molinaro GA, Kettering JD, Heiner DC, Imagawa DT, St Geme JW Jr. Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus. J Pediatr 1987;110:87-90.
56. Russi JC, Delfraro A, Borthagaray MD, Velazquez B, Garcia-Barreno B, Hortal M. Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopha- ryngeal secretions of children with respiratory syncytial virus infections. J Clin Microbiol 1993;31:819-23.
57. Cassimos DC, Tsalkidis A, Tripsianis GA, Stogiannidou A, Anthracopoulos M, Ktenidou-Kartali S, et al. Asthma, lung function and sensitization in school children with a history of bronchiolitis. Pediatr Int 2008;50:51-6.
58. Dakhama A, Lee YM, Ohnishi H, Jing X, Balhorn A, Takeda K, et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol 2009;123:138-45, e5.
59. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 2006;33:235-52.
60. Schafer T, Heinrich J, Wjst M, Krause C, Adam H, Ring J, et al. Indoor risk factors for atopic eczema in school children from East Germany. Environ Res 1999;81:151-8.
61. Berth-Jones J, George S, Graham-Brown RA. Predictors of atopic dermatitis in Leicester children. Br J Dermatol 1997;136:498-501.
62. Falk ES. Atopic diseases in Norwegian Lapps. Acta Derm Venereol Suppl (Stockh) 1993;182:10-4.
63. Schafer T, Vieluf D, Behrendt H, Kramer U, Ring J. Atopic eczema and other manifestations of atopy: results of a study in East and West Germany. Allergy 1996;51:532-9.
64. Dotterud LK, Kvammen B, Bolle R, Falk ES. A survey of atopic diseases among school children in Sor-Varanger community: possible effects of subarctic climate and industrial pollution from Russia. Acta Derm Venereol 1994;74:124-8.
65. Dotterud LK, Kvammen B, Lund E, Falk ES. Prevalence and some clinical aspects of atopic dermatitis in the community of Sor-Varanger. Acta Derm Venereol 1995; 75:50-3.
66. Herd RM, Tidman MJ, Prescott RJ, Hunter JA. Prevalence of atopic eczema in the community: the Lothian Atopic Dermatitis study. Br J Dermatol 1996;135:18-9.
67. Saval P, Fuglsang G, Madsen C, Osterballe O. Prevalence of atopic disease among Danish school children. Pediatr Allergy Immunol 1993;4:117-22.
68. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
69. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
70. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001;10:11-8.